This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H14N6 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H14N6 Hemagglutinin (HA), C-His is a recombinant protein expressed from Mammalian Expression System. Its predicted molecular weight is 64.7 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
HA is a type I transmembrane glycoprotein on the influenza virus surface, essential for viral entry. It functions by binding to host cell sialic acid receptors, triggering receptor-mediated endocytosis. Subsequently, HA undergoes a low-pH-induced conformational change in the endosome, facilitating the fusion of the viral envelope with the host membrane. As the primary target for neutralizing antibodies, HA is a critical antigen for vaccine development and a key determinant of viral host range and pathogenicity in H14N6 strains.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.